Rocket Pharmaceuticals, Inc. Income Statement

Income Statement Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.88M-0.98M-1.23M-6.04M-5.96M-6.97M-2.98M-1.86M-1.88M-1.89M
Gross Profit 0.88M-0.98M-1.23M-6.04M-5.96M-6.97M-2.98M-1.86M-1.88M-1.89M
Operating items
Amortization - Intangibles 0.80M1.18M-0.58M-2.91M-0.05M10.65M8.08M
Research & Development 5.33M5.59M12.55M5.99M14.92M53.27M57.91M105.44M125.48M165.57M186.34M171.24M
Selling, General & Administrative -1.32M2.11M7.84M1.58M4.86M17.89M18.24M28.86M41.77M58.77M73.32M101.96M
Other Operating Expenses -10.66M-15.41M-35.76M-78.25M
Operating Expenses -6.65M-7.70M20.40M7.57M19.77M71.16M76.15M134.30M167.25M224.34M259.66M273.20M
Operating Income -7.70M-20.40M-7.57M-19.77M-71.16M-76.15M-134.30M-167.25M-224.34M-259.66M-273.20M
EBIT -7.70M-20.40M-7.57M-19.77M-71.16M-76.15M-134.30M-167.25M-224.34M-259.66M-273.20M
Non-operating items
Interest & Investment Income 0.09M0.00M0.00M1.69M3.41M2.15M3.07M3.89M5.29M8.27M
Other Non Operating Income -42.79M
Non Operating Income -0.08M-0.85M-5.40M-1.82M2.48M
Net income details
EBT -8.68M-21.54M-7.57M-19.77M-75.50M-78.69M-139.12M-167.16M-222.32M-256.25M-266.82M
Profit After Tax 6.06M7.62M-9.53M-67.98M-7.57M-19.58M-74.52M-77.27M-139.70M-169.07M-221.86M-245.59M-258.75M
Income from Continuing Operations -8.68M-21.54M-7.57M-19.77M-75.50M-78.69M-139.12M-167.16M-222.32M-256.25M-266.82M
Consolidated Net Income -8.68M-21.54M-7.57M-19.77M-75.50M-78.69M-139.12M-167.16M-222.32M-256.25M-266.82M
Income towards Parent Company -8.68M-21.54M-7.57M-19.77M-75.50M-78.69M-139.12M-167.16M-222.32M-256.25M-266.82M
Net Income towards Common Stockholders -8.68M-21.54M-7.57M-19.58M-74.52M-77.27M-139.70M-169.07M-221.86M-245.59M-258.75M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 3.97M6.60M6.73M6.81M39.84M50.38M55.23M64.44M75.68M90.16M91.16M
Shares Outstanding (Diluted Average) 49.01M55.38M63.24M68.15M84.01M94.81M
EBITDA -7.70M-20.40M-7.57M-19.77M-71.16M-76.15M-134.30M-167.25M-224.34M-259.66M-273.20M